Form 10-Q CYTRX CORP For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
- SanDisk upgraded at JPMorgan after investor day; shares climb
CytRx (CYTR) Still Trades at Favorable Valuation to Peers; Aegis Maintains 'Buy' Rating
August 7, 2014 11:28 AM EDTAegis Capital affirms its Buy rating and $12 target price on CytRx Corp. (Nasdaq: CYTR) following Q2 results and update.
Analyst Ram Selvaraju commented, The firm ended the quarter with $102.5mm in cash, which we expect to be sufficient to fund operations well into 2016, past a... More
CytRx (CYTR) Presents Significant Aldoxorubicin Phase 2b Data
August 7, 2014 6:09 AM EDTCytRx (Nasdaq: CYTR) announced that its oral presentation given by Sant P. Chawla, M.D., F.R.A.C.P., Director of the Sarcoma Oncology Center, titled Randomized phase 2b trial comparing first-line treatment with aldoxorubicin versus doxorubicin in patients with advanced soft tissue sarcomas, was featured in The Lancet Oncology in its July 2014 issue (Volume 15, Issue 8) in a review of the major presentations from the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting.
We are honored to have been included in The Lancet Oncologys... More
CytRx Corp (CYTR) Posts Q2 Loss of 28c/Share
August 6, 2014 6:10 AM EDTCytRx Corp (NASDAQ: CYTR) reported Q2 EPS of ($0.28), $0.08 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on CytRx Corp (CYTR) click here.
... More